Latest News

Professor Bruce Robinson has been appointed the NSLHD Chair of Research in an important step towards strengthening research expertise across the district. Professor Robinson, a Kolling Institute researcher, will step into the newly created role this month, bringing a tremendous wealth of research, clinical and policy experience with him. Bruce will be responsible for providing leadership and strate.....
Read more

We may soon have a safer approach to diagnosing and measuring the progression of chronic kidney disease following new research by the team from the Kolling Institute’s Renal Research Laboratory. The condition is a global health issue, which now affects more than 13 per cent of the worldwide population. Chronic kidney disease is a progressive disease that leads to end-stage kidney failure, which is.....
Read more

Professor Jim Elliott has been appointed the Kolling Institute’s new Academic Director. Professor Elliott brings a wealth of experience to the position including a research career spanning more than two decades. He is recognised as a global expert in neck pain and whiplash injuries and leads large scale, multi-centre projects involving collaborators from across the globe. During a period as the Kol.....
Read more

Our researchers are seeking participants for a large-scale clinical trial pioneering the use of stem cells to treat and potentially cure osteoarthritis. The disease is now one of the leading causes of disability in the world, affecting around three million people in Australia alone. Royal North Shore Hospital rheumatologist Professor David Hunter is leading the two-year trial which is recruiting ar.....
Read more

Researchers at the Kolling Institute are increasingly forging partnerships with industry, with the collaborative efforts accelerating improvements in patient care. One team which has particularly benefitted from a strong relationship with industry partners is the diverse group from the Murray Maxwell Biomechanics Laboratory. Director, Associate Professor Liz Clarke is encouraging others to follow s.....
Read more

An impressive group of emerging leaders addressed the Kolling’s Neuroscience and Pain Showcase, sharing details of their diverse and exciting research projects. With a broad range of expertise in this field, the showcase involved representatives from the pain management and rehabilitations teams, as well as the ageing, mental health, neurogenetics and neuromuscular imaging groups. The early and mid.....
Read more

We would like to congratulate our Kolling Institute researcher Professor Sarah Hilmer who’s been awarded an AM for her service to clinical and geriatric pharmacology as part of the Queen’s birthday honours. Professor Hilmer has worked as the Head of Clinical Pharmacology and as a geriatrician at Royal North Shore Hospital since 2005. Her research and clinical expertise is respected both nationally .....
Read more

The largest study in Australia into the treatment of juvenile arthritis may pave the way for a unique approach to care for those with the disabling condition and dramatically improve outcomes. The Medical Research Future Fund will invest $2.5 million in the A3BC for Kids project which will involve researchers from the Kolling Institute and the University of Sydney in collaboration with the Australi.....
Read more

New funding will see a large-scale project launched across NSW to significantly improve patient outcomes and experiences in Emergency Departments. Chief investigator and Kolling Institute researcher Professor Margaret Fry said more than $2.8 million will be invested in the EPIC-START program, giving patients better access to early evidence-based treatment pathways. 30 Emergency Departments will ini.....
Read more

New research by a team from the Kolling Institute has found the best treatment for chronic low back pain doesn’t just focus on the physical, but combines physiotherapy treatments with those focusing on the mind. The study, involving Emma Ho, Professor Manuela Ferreira and Lingxiao Chen, analysed evidence from almost 100 trials worldwide involving over 13,000 patients. It found a combination of phys.....
Read more